Ambev Stock Forecast, Price & News

+0.02 (+0.62 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume28.16 million shs
Average Volume24.37 million shs
Market Capitalization$51.14 billion
P/E Ratio19.12
Dividend Yield0.32%
30 days | 90 days | 365 days | Advanced Chart
Receive ABEV News and Ratings via Email

Sign-up to receive the latest news and ratings for Ambev and its competitors with MarketBeat's FREE daily newsletter.

Ambev logo

About Ambev

Ambev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food products in the Americas. It operates through three segments: Brazil; Central America and the Caribbean; Latin America South; and Canada. The company offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Budweiser, Bud Light, Stella Artois, Corona, Modelo Especial, Beck, Leffe, Hoegaarden, Bucanero, Cristal, Mayabe, Cacique, Presidente, Brahma Light, President Light, Bohemia, The One, Banks, Deputy, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Pilsen, Ouro Fino, Patricia, Michelob Ultra, Busch, Labatt Blue, Alexander Keith's, and Kokanee brands. It also provides bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Natu, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi, Canada Dry, Squirt, Red Rock, Pepsi-Cola, Seven Up, Nutrl, and Palm Bay and Mike's brands, as well as For Me wellness shots, a functional beverage. Ambev S.A. offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. is a subsidiary of Interbrew International B.V.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.06 out of 5 stars

Consumer Staples Sector

82nd out of 175 stocks

Beverages Industry

7th out of 13 stocks

Analyst Opinion: 2.1Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Ambev (NYSE:ABEV) Frequently Asked Questions

Is Ambev a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ambev in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Ambev stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABEV, but not buy additional shares or sell existing shares.
View analyst ratings for Ambev
or view top-rated stocks.

What stocks does MarketBeat like better than Ambev?

Wall Street analysts have given Ambev a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ambev wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Ambev?

Ambev saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 56,230,000 shares, a drop of 20.5% from the June 15th total of 70,760,000 shares. Based on an average daily trading volume, of 24,090,000 shares, the days-to-cover ratio is currently 2.3 days.
View Ambev's Short Interest

When is Ambev's next earnings date?

Ambev is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Ambev

How were Ambev's earnings last quarter?

Ambev S.A. (NYSE:ABEV) posted its earnings results on Wednesday, July, 28th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The firm earned $2.97 billion during the quarter, compared to the consensus estimate of $2.93 billion. Ambev had a net margin of 21.91% and a trailing twelve-month return on equity of 18.82%.
View Ambev's earnings history

How has Ambev's stock been impacted by COVID-19?

Ambev's stock was trading at $2.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ABEV stock has increased by 14.0% and is now trading at $3.25.
View which stocks have been most impacted by COVID-19

How often does Ambev pay dividends? What is the dividend yield for Ambev?

Ambev declared a -- dividend on Thursday, December 31st. Investors of record on Friday, January 15th will be paid a dividend of $0.0483 per share on Monday, February 8th. This represents a dividend yield of 3.1%. The ex-dividend date is Thursday, January 14th.
View Ambev's dividend history

Is Ambev a good dividend stock?

Ambev pays an annual dividend of $0.01 per share and currently has a dividend yield of 0.32%. The dividend payout ratio of Ambev is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Ambev will have a dividend payout ratio of 7.14% next year. This indicates that Ambev will be able to sustain or increase its dividend.
View Ambev's dividend history.

What price target have analysts set for ABEV?

9 brokerages have issued 12-month target prices for Ambev's stock. Their forecasts range from $3.60 to $4.00. On average, they anticipate Ambev's stock price to reach $3.80 in the next year. This suggests a possible upside of 16.9% from the stock's current price.
View analysts' price targets for Ambev
or view top-rated stocks among Wall Street analysts.

Who are Ambev's key executives?

Ambev's management team includes the following people:
  • Mr. Jean Jereissati Neto, CEO & Member of Exec. Board (Age 47)
  • Mr. Lucas Machado Lira, CFO, Investor Relations & Shared Services Officer and Member of Board of Exec. Officers (Age 44)
  • Mr. Eduardo Braga Cavalcanti de Lacerda, VP Officer of Commercial & Member of Exec. Board of Officers (Age 44)
  • Mr. Ricardo Morais Pereira de Melo, VP Officer of People and Management & Member of Exec. Board of Officers (Age 49)
  • Mr. Rodrigo Figueiredo de Souza, VP Officer of Procurement & Member of Exec. Board of Officers (Age 45)
  • Mr. Mauricio Nogueira Soufen, Industrial VP Officer & Member of Exec. Board of Officers (Age 47)
  • Mr. Daniel Cocenzo, VP Officer of Sales & Member of Exec. Board of Officers (Age 46)
  • Ms. Leticia Rudge Barbosa Kina, VP Officer of Legal & Compliance, Member of Exec. Board of Officers and Sec. (Age 44)
  • Mr. Ricardo Gonçalves Melo, VP Officer of Corp. Affairs & Member of Exec. Board of Officers (Age 50)
  • Mr. Paulo André Zagman, VP Officer of Logistics & Member of Exec. Board of Officers (Age 44)

Who are some of Ambev's key competitors?

What other stocks do shareholders of Ambev own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ambev investors own include General Electric (GE), Vale (VALE), Anheuser-Busch InBev SA/NV (BUD), Ford Motor (F), NVIDIA (NVDA), AT&T (T), Intel (INTC), Advanced Micro Devices (AMD), Micron Technology (MU) and Exxon Mobil (XOM).

What is Ambev's stock symbol?

Ambev trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABEV."

Who are Ambev's major shareholders?

Ambev's stock is owned by many different retail and institutional investors. Top institutional investors include RWC Asset Management LLP (0.03%), Sumitomo Mitsui Trust Holdings Inc. (0.02%), Fisher Asset Management LLC (0.01%), Avalon Investment & Advisory (0.01%), Oppenheimer Asset Management Inc. (0.01%) and Oppenheimer & Co. Inc. (0.00%).

Which institutional investors are selling Ambev stock?

ABEV stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Oppenheimer Asset Management Inc., First Personal Financial Services, Sumitomo Mitsui Trust Holdings Inc., Advisor Group Holdings Inc., Bay Colony Advisory Group Inc d b a Bay Colony Advisors, and Sequoia Financial Advisors LLC.

Which institutional investors are buying Ambev stock?

ABEV stock was acquired by a variety of institutional investors in the last quarter, including RWC Asset Management LLP, Investment Management Associates Inc. ADV, DAVENPORT & Co LLC, Avalon Investment & Advisory, Mraz Amerine & Associates Inc., Marino Stram & Associates LLC, Brinker Capital Investments LLC, and Oppenheimer & Co. Inc..

How do I buy shares of Ambev?

Shares of ABEV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ambev's stock price today?

One share of ABEV stock can currently be purchased for approximately $3.25.

How much money does Ambev make?

Ambev has a market capitalization of $51.14 billion and generates $11.33 billion in revenue each year. The company earns $2.21 billion in net income (profit) each year or $0.14 on an earnings per share basis.

How many employees does Ambev have?

Ambev employs 50,479 workers across the globe.

When was Ambev founded?

Ambev was founded in 1998.

What is Ambev's official website?

The official website for Ambev is www.ambev.com.br.

Where are Ambev's headquarters?

Ambev is headquartered at RUA DR. RENATO PAES DE BARROS 1017 3 ANDAR PARTE, SAO PAULO D5, 04530-001.

How can I contact Ambev?

Ambev's mailing address is RUA DR. RENATO PAES DE BARROS 1017 3 ANDAR PARTE, SAO PAULO D5, 04530-001. The company can be reached via phone at 55-11-2122-1200 or via email at [email protected]

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.